ArticleHealth science reports2025
Barriers and Solutions to Implement HIV Pre-Exposure Prophylaxis Program Among Key Populations in Iran: A Qualitative Study Using Causal Layered Analysis.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: HIV pre-exposure prophylaxis (PrEP) has a crucial role in HIV prevention globally. Our study aimed to explore the approaches to address and overcome barriers to PrEP implementation among key populations in Iran. Methods: In this multi-stage qualitative study, first, we employed in-depth interviews to identify possible barriers to PrEP implementation in Iran. Second, we conducted three focus group discussions with HIV experts to categorize barriers to PrEP implementation among key populations using the Causal layered analysis. Last, we collected HIV expert's opinions on possible solutions to overcome the barriers. Results: We found four layers of barriers (including potential solutions) in PrEP implementation: litany, systemic causes, and discourse/myth. In the litany layer, increasing HIV knowledge among key populations and healthcare providers was identified as a solution. In the systemic layer, cooperation and coordination among all societal organizations and providers were reported as a solution. In the discourse/myth layer, gaining the trust of the key populations, providing PrEP in private sectors, using telemedicine, and religious beliefs were identified as solutions. Conclusion: Our deep multi-step qualitative analysis showed that barriers to implementing PrEP in Iran are several, complex, and cross-cutting. Addressing them requires interventions among key populations at risk for HIV, such as PrEP users, health providers, and the community in general, to build a supportive environment for PrEP as one of the HIV prevention strategies in Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.